Engineering mouse cell fate controller by rational design.
Tao HuangDong LiuXiaomin WangJunqi KuangManqi WuBeibei WangZechuan LiangYixin FanBo ChenZhaoyi MaYu FuWenhui ZhangJin MingYue QinChengchen ZhaoBo WangDuan-Qing PeiPublished in: Nature communications (2024)
Cell fate is likely regulated by a common machinery, while components of this machine remain to be identified. Here we report the design and testing of engineered cell fate controller Nanog BiD , fusing BiD or BRG1 interacting domain of SS18 with Nanog. Nanog BiD promotes mouse somatic cell reprogramming efficiently in contrast to the ineffective native protein under multiple testing conditions. Mechanistic studies further reveal that it facilitates cell fate transition by recruiting the intended Brg/Brahma-associated factor (BAF) complex to modulate chromatin accessibility and reorganize cell state specific enhancers known to be occupied by canonical Nanog, resulting in precocious activation of multiple genes including Sall4, miR-302, Dppa5a and Sox15 towards pluripotency. Although we have yet to test our approach in other species, our findings suggest that engineered chromatin regulators may provide much needed tools to engineer cell fate in the cells as drugs era.
Keyphrases
- cell fate
- transcription factor
- genome wide
- single cell
- cancer stem cells
- dna damage
- gene expression
- cell therapy
- induced apoptosis
- long non coding rna
- cell proliferation
- magnetic resonance
- stem cells
- embryonic stem cells
- copy number
- cell cycle arrest
- magnetic resonance imaging
- computed tomography
- cell death
- bone marrow
- protein protein
- small molecule
- amino acid
- drug induced